Using targeted LC-MS/MS, we quantified the N368-cleaved Tau in the sarkosyl-soluble SS1 and S3 extracts (Additional file 1: Figure S1 and Methods) of hippocampus from Braak stage I/II control subjects and Braak stage V/VI AD patients (Fig. 5). The gene discussed is MAPT; the disease is Alzheimer disease.